SHARON L PEARCE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Community Health APALACHIN, NY NPI 1558736355

General Payments — all program years on this page

$2,744.46

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 125
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $320.10 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $320.1019

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $863.4847
2022 $1,114.0538
2023 $446.8321
2024 $320.1019

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101488964 E.R. Squibb & Sons, L.L.C. $18.15 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101489001 E.R. Squibb & Sons, L.L.C. $13.75 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101489021 E.R. Squibb & Sons, L.L.C. $16.16 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104681525 AstraZeneca Pharmaceuticals LP $18.52 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105470451 AstraZeneca Pharmaceuticals LP $15.90 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105637724 AstraZeneca Pharmaceuticals LP $13.89 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105638962 AstraZeneca Pharmaceuticals LP $13.86 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105811307 AstraZeneca Pharmaceuticals LP $17.03 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114498154 Exact Sciences Corporation $22.32 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114498160 Exact Sciences Corporation $18.93 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115939930 GlaxoSmithKline, LLC. $14.40 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116101230 GlaxoSmithKline, LLC. $16.95 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116393610 GlaxoSmithKline, LLC. $14.69 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116427662 GlaxoSmithKline, LLC. $16.47 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127055803 Kyowa Kirin, Inc. $18.04 02/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135947595 Lilly USA, LLC $18.81 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151195785 Phathom Pharmaceuticals, Inc. $17.41 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151195787 Phathom Pharmaceuticals, Inc. $17.41 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151195789 Phathom Pharmaceuticals, Inc. $17.41 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.